Yin, NJ
Hequn Yin, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20090176739 | OPTICAL ISOMERS OF AN ILOPERIDONE METABOLITE - The present invention relates to novel isomers of a metabolite of Iloperidone, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them. | 07-09-2009 |
20110201646 | OPTICAL ISOMERS OF AN ILOPERIDONE METABOLITE - The present invention relates to novel isomers of a metabolite of Iloperidone, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them. | 08-18-2011 |
20130296366 | OPTICAL ISOMERS OF AN ILOPERIDONE METABOLITE - The present invention relates to novel isomers of a metabolite of Iloperidone, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them. | 11-07-2013 |
Jain Yin, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20110300488 | Antireflective Coating Composition and Process Thereof - The invention related to an antireflective coating comprising a mixture of a first polymer and a second polymer, and a thermal acid generator, where the first polymer comprises at least one fluoroalcohol moiety, at least one aliphatic hydroxyl moiety, and at least one acid moiety other than fluoroalcohol with a pKa in the range of about 8 to about 11; where the second polymer is a reaction product of an aminoplast compound with a compound comprising at least one hydroxyl and/or at least one acid group. The invention further relates to a process for using the novel composition to form an image. | 12-08-2011 |
Jianguo Yin, Plainsboro, NJ US
Patent application number | Description | Published |
---|---|---|
20080279822 | Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand - The present invention relates to four distinct crystalline polymorphs of a monohydrate of Compound A having the following chemical structure: | 11-13-2008 |
20100137597 | SYNTHESIS Of DIETHYLPHOSPHONATE - This application discloses a novel process for the preparation of phosphonate esters useful as intermediates in the preparation of himbacine analogs, themselves useful as thrombin receptor antagonists. The chemistry taught herein can be exemplified by the following scheme: | 06-03-2010 |
20110124867 | Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist Activity - The present invention relates to novel processes for the preparation of the compound of the Formula A45: | 05-26-2011 |
20150038707 | PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS - Methods for preventing pest infestations are disclosed. In some embodiments, the methods for preventing infestations involve use of pyrethroid insecticides or the stereoisomers or salts thereof. | 02-05-2015 |
20150112067 | PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS - The disclosure encompasses a novel process for making piperidinone carboxamide indane and azainane derivatives, having less steps and improved yields as compared to previous synthetic methods for making these compounds, which are CGRP receptor antagonists, useful for the treatment of migraine. Conditions for an amide bond formation between an acid and amine include for example reacting the compounds of Formulae B (after salt break) and C with an amide coupling reagent and optionally an additive and an acid and/or a base in a non-reactive solvent. | 04-23-2015 |
Jianguo Yin, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20090048458 | SYNTHESIS OF 2-HYDROXY-N,N-DIMETHYL-3-[[2-[[1(R)-(5-METHYL-2-FURANYL)PROPYL]AMINO]-3,4- -DIOXO-1-CYCLOBUTEN-1-YL]AMINO]BENZAMIDE - Disclosed is a process for making the compound of formula I: | 02-19-2009 |
Jin Yin, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20150158907 | METHODS AND SYSTEMS FOR PROCESSING A CELL CULTURE - Provided herein are methods of processing a cell culture and open circuit filtration systems. | 06-11-2015 |
Jingjun Yin, Green Brook, NJ US
Patent application number | Description | Published |
---|---|---|
20100036135 | Process for Making Hydroisoindoline Tachykinin Receptor Antagonists - The present invention is directed to a process for preparing certain hydroisoindoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The compounds are useful in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety. | 02-11-2010 |
20100087419 | HIV INTEGRASE INHIBITORS - Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: | 04-08-2010 |
20130149751 | PROCESS FOR PREPARING AMINOCYCLOHEXYL ETHER COMPOUNDS - The present invention relates to a process for preparing aminocyclohexyl ether compounds of Formula I: or the pharmaceutically acceptable salts and esters thereof. In particular, the instant invention is directed towards a process for preparing (1R,2R)-2-[(3R)-Hydroxypyrrolidinyl]-1-(3,4-dimethoxyphenethoxy)-cyclohexane as well as various intermediates. | 06-13-2013 |
20130338141 | HIV INTEGRASE INHIBITORS - Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: | 12-19-2013 |
20150259284 | PROCESS FOR PREPARING AMINOCYCLOHEXYL ETHER COMPOUNDS - The present invention relates to a process for preparing aminocyclohexyl ether compounds of Formula I: | 09-17-2015 |
20150284753 | PROCESS FOR THE PREPARATION OF AN INTERMEDIATE FOR AN OREXIN RECEPTOR ANTAGONISTS - The present invention is directed to processes for preparing an intermediate for a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. | 10-08-2015 |
Jungjun Yin, Green Brook, NJ US
Patent application number | Description | Published |
---|---|---|
20110237634 | NOVEL CRYSTALLINE FORMS OF AN INHIBITOR OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 - Novel crystalline salts of 3-[4-(3-ethanesulfonyl-propyl)-bicyclo[2.2.2]oct-1-yl]-4-methyl-5-(2-trifluoromethyl-phenyl)-4H-1,2,4-triazole are potent inhibitors of 11β-hydroxysteroid dehydrogenase Type 1 and are useful for the treatment of conditions associated with Metabolic Syndrome as well as cognitive impairment. The invention also relates to pharmaceutical compositions containing these novel salts, processes to prepare these salts and their pharmaceutical compositions as well as uses thereof for the treatment of Type 2 diabetes, hyperglycemia, obesity, dyslipidemia, hypertension, and cognitive impairment. | 09-29-2011 |
Kingsley Yin, Cherry Hill, NJ US
Patent application number | Description | Published |
---|---|---|
20120220658 | Method for Treating Sepsis or Septic Shock - The present invention is a method for treating sepsis or septic shock using Lipoxin A4. | 08-30-2012 |
Lun Yin, Jersey City, NJ US
Patent application number | Description | Published |
---|---|---|
20150289488 | SYSTEM FOR CREATING A VERTICAL WATER FLOW IN A WATER COLUMN - A system for creating a vertical water flow in a water column that includes a first portion, and a second deeper portion is provided including a down-welling mechanism positioned within the water column. The down-welling mechanism is configured to create the vertical water flow downward to the second, deeper portion of the water column. | 10-15-2015 |
Ophelia Yin, Denville, NJ US
Patent application number | Description | Published |
---|---|---|
20120202836 | METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY - The present invention relates to a regimen for the administration of a pyrimidylaminobenzamide of formula I as defined herein for the treatment of proliferative disorders, particularly solid and liquid tumors, and other pathological conditions mediated by the Bcr-AbI oncoprotein, the cell transmembrane tyrosine kinase receptor c-Kit, DDR1 (discoidin domain receptor 1), DDR2 (discoidin domain receptor 2) or PDGF-R (platelet derived growth factor receptor) kinase activity. | 08-09-2012 |
20120289528 | METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY - The present invention relates to a regimen for the administration of a pyrimidylaminobenzamide of formula I | 11-15-2012 |
20140350037 | METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY - The present invention relates to a regimen for the administration of a pyrimidylaminobenzamide of formula I as defined herein for the treatment of proliferative disorders, particularly solid and liquid tumors, and other pathological conditions mediated by the Bcr-Abl oncoprotein, the cell transmembrane tyrosine kinase receptor c-Kit, DDR1 (discoidin domain receptor 1), DDR2 (discoidin domain receptor 2) or PDGF-R (platelet derived growth factor receptor) kinase activity. | 11-27-2014 |
Peng Yin, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20090196342 | Adaptive Geometric Partitioning For Video Encoding - There are provided methods and apparatus for adaptive geometric partitioning for video encoding and decoding. An apparatus includes an encoder for encoding image data corresponding to pictures by adaptively partitioning at least portions of the pictures responsive to at least one parametric model. The at least one parametric model involves at least one of implicit and explicit formulation of at least one curve. | 08-06-2009 |
Si Yin, Kearny, NJ US
Patent application number | Description | Published |
---|---|---|
20090046574 | Virtual Circuit Connectivity Verification Insertion for Packet Loss Control in Pseudowire - A method includes inserting a virtual circuit connectivity verification packet into aggregated traffic of m packets transmitted over multiple pseudowires in a network path, replying to the transmitted m packets with a virtual circuit connectivity verification packet with a packet loss indication when at least one packet loss is detected in an m packet group, and adjusting a rate of transmitting the aggregated m packets responsive to the packet loss indication. In the preferred embodiment the multiple pseudowires are one of constant bit rate and variable bit rate and the adjusting of the rate includes rate adjustment of variable bit rate pseudowires. | 02-19-2009 |
20090060503 | STORAGE OVER OPTICAL/WIRELESS INTEGRATED BROADBAND ACCESS NETWORK (SOBA) ARCHITECTURE - An optical line terminal (OLT), network and method include input and output switching modules configured to switch between input and output channels. A transmission module is configured for physical layer transmission using at least one of a plurality of transmission technologies to provide multiple uses of an existing transmission line. A dynamic resource module is configured to allocate network resources dynamically to one or more storage area networks (SAN) based on storage resource requests. A service differentiation module is configured to determine and implement different service levels for SAN users. An existing network infrastructure is enabled to provide custom SAN services without a dedicated line and without interfering with existing services. | 03-05-2009 |
20090067839 | STORAGE AREA NETWORK EXTENSION OVER PASSIVE OPTICAL NETWORKS USING PARALLEL SIGNAL DETECTION - A storage area network extension, network and method include a storage terminal coupled to a remote node. The remote node is connected to a passive optical network (PON) for transferring data signals in the PON and storage signals to/from the storage terminal by employing subcarrier channels in the PON to enable concurrent bidirectional transfer of the data and the storage signals. A storage area network is coupled to the storage terminal and configured to store and retrieve the storage signals for transfer over the PON. | 03-12-2009 |
Wei Yin, Jersey City, NJ US
Patent application number | Description | Published |
---|---|---|
20150294028 | Systems and Methods for Dynamic Construction of Entity Graphs - The present disclosure includes a system, method, and article of manufacture for generating an entity graph. The method may comprise determining a relationship between a first entity and a second entity based upon internal data, external data, and/or online data associated with the first entity, and generating the entity graph comprising at least two nodes and an edge connecting the at least two nodes. The method may further comprise, in various embodiments, tailoring marketing to the first entity based upon the entity graph, detecting fraud against the first entity based upon the entity graph, periodically updating the entity graph based upon new internal data and new online data, and/or adjusting the edge based upon a change in the relationship between the first entity and the second entity. | 10-15-2015 |
Xiaotian Yin, New Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20130039989 | PHARMACEUTICAL COMPOSITIONS COMPRISING N-(4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUO- ROPHENYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE - Disclosed are salts and crystalline forms of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide and salts thereof. Also disclosed are at least one pharmaceutical composition comprising at least one crystalline form of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide, at least one method of using at least one crystalline form of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide to treat cancer and/or other proliferative diseases, and processes to prepare crystalline forms of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide and salts thereof. | 02-14-2013 |
Xiaotian S. Yin, Plainsboro, NJ US
Patent application number | Description | Published |
---|---|---|
20090054303 | CRYSTAL FORMS OF SAXAGLIPTIN AND PROCESSES FOR PREPARING SAME - Physical crystal structures of a compound of the formula I: | 02-26-2009 |
Xiaotian S. Yin, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20110257085 | Crystal Forms of Saxagliptin and Processes for Preparing Same - Physical crystal structures of a compound of the formula I: | 10-20-2011 |
20120283181 | CRYSTAL FORMS OF SAXAGLIPTIN AND PROCESSES FOR PREPARING SAME - Physical crystal structures of a compound of the formula I: | 11-08-2012 |
20140121155 | Crystal Forms of Saxagliptin and Processes for Preparing Same - Physical crystal structures of a compound of the formula I: | 05-01-2014 |
Yafeng Yin, Harrison, NJ US
Patent application number | Description | Published |
---|---|---|
20150235379 | SYSTEM AND METHOD FOR PROCESSING VISUAL INFORMATION FOR EVENT DETECTION - A system and method processes visual information including at least one object in motion. The visual information is processed by locating at least one spatial edge of the object, generating a plurality of spatio-temporal gradients for the at least one spatial edge over N frames, and then generating motion blur images from the spatio-temporal gradients. A regression analysis is performed on the motion blur images to determine direction of motion information of the object, and scene activity vectors are then generated for the N frames based on the direction of motion information. An event is detected in the visual information based on the scene activity vectors. | 08-20-2015 |
Yan Yin, Lake Hiawath, NJ US
Patent application number | Description | Published |
---|---|---|
20120158432 | Patient Information Documentation And Management System - A method and system for documenting and managing patient information in real time for accurate medical examination and treatment of a patient is provided. An information carrier device that stores patient information is provided to the patient. A data extraction unit extracts the stored patient information from the information carrier device and transmits the extracted patient information to a patient information processing system. A recording unit records observational data comprising medical examination information and information on treatment prescribed for the patient. The patient information processing system processes and analyzes the patient information received from the information carrier device and/or the data extraction unit and the observational data extracted from the recording unit, generates a medical examination report in one or more of multiple formats, and transmits the medical examination report in one or more formats to the information carrier device for updating the patient information in the information carrier device. | 06-21-2012 |
Yawei Yin, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20150104171 | Burst Switching System Using Optical Cross-Connect as Switch Fabric - A switching system includes one or more line card for input processing, forwarding, queuing, and scheduling data, the line card having a tunable laser to select a wavelength according to the packets' destination for a given burst of packets, so that the burst is switched to a desired destination and sent all-optically to a connected interface; an all-optical switch fabric coupled to the line card to perform wavelength switching; and a centralized arbitrator that resolves the contention from different input ports. | 04-16-2015 |
Yawei Yin, Plainsboro, NJ US
Patent application number | Description | Published |
---|---|---|
20150147060 | HYBRID ELECTRO-OPTICAL DISTRIBUTED SOFTWARE-DEFINED DATA CENTER ARCHITECTURE - A hybrid electro-optical data center system includes multiple tiers. A bottom tier has one or more bottom tier instances, with each bottom tier instance including one or more racks, an electro-optical switch corresponding to each rack, and a first bottom tier optical loop providing optical connectivity between the electro-optical switches of the respective bottom tier instance. At least one server within each rack is electrically connected to the respective electro-optical switch and at least one super-server within each rack is electrically and optically connected to the respective electro-optical switch. A top tier includes electro-optical switches, each electrically connected to an electro-optical switch in a respective bottom tier instance, a first top tier optical loop providing optical connectivity between the electro-optical switches of the top tier, and one or more optical add/drop modules providing optical connectivity between the first bottom tier optical loop and the first top tier optical loop. | 05-28-2015 |
20150181317 | SCALABLE HYBRID PACKET/CIRCUIT SWITCHING NETWORK ARCHITECTURE - Systems and methods for packet switching in a network, including two or more hybrid packet/circuit switching network architectures configured to connect two or more core level switches in the network architectures, the network architectures being controlled and managed using a centralized software defined network (SDN) control plane. An optical ring network may be configured to interconnect the two or more hybrid network architectures, and one or more hybrid electrical/optical packet/circuit switches configured to perform switching and traffic aggregation. One or more high-speed optical interfaces and one or more low-speed electrical/optical interfaces may be configured to transmit data. | 06-25-2015 |
20150295756 | Hybrid Optical/Electrical Interconnect Network Architecture for Direct-connect Data Centers and High Performance Computers - The present invention proposes a hybrid optical/electrical network architecture for the direct-connect datacenters and HPC systems. It utilizes small scale optical switches in parallel with the electrical switching modules (e.g. the multi-port NIC) in the direct-connect electrical network (e.g 3D Torus) in order to provide optical bypassing capabilities. The optical network keeps the same topology as the electrical packet switching network, while the number of optical nodes can be equal or less than the electrical switching modules. | 10-15-2015 |
Yu Yin, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20100128864 | METHOD AND SYSTEM FOR OVERRIDING CALL BLOCKING - An approach is provided for overriding a call blocking feature. A request to establish a voice call over a wireless network to a called party is intercepted. A call blocking feature is detected as being enabled for the called party. The calling party is prompted for a passcode in response to the detected call blocking feature. The passcode is received from the calling party to override the call blocking feature. | 05-27-2010 |